DRI Healthcare Trust (DHT-U) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DRI Healthcare Trust (DHT-U) has a cash flow conversion efficiency ratio of 0.053x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($26.92 Million) by net assets ($503.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DHT-U market cap overview for the company's overall valuation and market capitalisation.
DRI Healthcare Trust - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how DRI Healthcare Trust's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DRI Healthcare Trust Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DRI Healthcare Trust ranked by their cash flow conversion efficiency. Explore DRI Healthcare Trust (DHT-U) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hainan Haiqi Transportation Group Co Ltd
SHG:603069
|
-0.017x |
|
MN Holdings Berhad
KLSE:0245
|
-0.055x |
|
Hg Technologies Co Ltd
SHE:300847
|
0.031x |
|
Complete Logistic Services Bhd
KLSE:5136
|
0.029x |
|
Zhejiang Noblelift Equip
SHG:603611
|
0.154x |
|
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
|
-0.068x |
|
Luyan Pharma Co Ltd
SHE:002788
|
0.035x |
|
Wolong Real Estate Group Co Ltd
SHG:600173
|
0.016x |
Annual Cash Flow Conversion Efficiency for DRI Healthcare Trust (2020–2024)
The table below shows the annual cash flow conversion efficiency of DRI Healthcare Trust from 2020 to 2024. View today's stock price for DRI Healthcare Trust for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $527.53 Million | $155.41 Million | 0.295x | +114.05% |
| 2023-12-31 | $561.50 Million | $77.28 Million | 0.138x | -33.85% |
| 2022-12-31 | $372.34 Million | $77.47 Million | 0.208x | -14.17% |
| 2021-12-31 | $378.99 Million | $91.86 Million | 0.242x | +100.00% |
| 2020-12-31 | $-352.00 | $91.86 Million | -260977.273x | -- |
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.